Development of Improved Adenosine Deaminase Retroviral Vectors

A series of adenosine deaminase (ADA) retroviral vectors were designed and constructed with the goal of improved performance over the PA317/LASN vector currently used in clinical trials. First, the bacterial selectable-marker neomycin phosphotransferase (neo) gene was removed to create a “simplified...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Onodera, Masafumi, Nelson, David M., Yachie, Akihiro, Jagadeesh, G. Jayashree, Bunnell, Bruce A., Morgan, Richard A., Blaese, R. Michael
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society for Microbiology 1998
Gaiak:
Gene Therapy
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC109465/
https://ncbi.nlm.nih.gov/pubmed/9499026
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak